Top Markets
#1 0G 0G +47.07%
#2 Merlin's Seal BTC Merlin's Seal BTC +42.87%
#3 Useless Coin Useless Coin +34.62%
#4 SAFEcoin SAFEcoin +28.92%
#5 Pons Pons +23.72%
#6 Dogs Dogs +21.97%
#7 StonkBroker StonkBroker +21.42%
#8 ICON ICON +20.51%
#9 Zora Zora +19.26%
#10 Fake World Assets Fake World Assets +17.51%
Coin of the day
0G 0G
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Ever Supreme Bio Technology Co., Ltd Ever Supreme Bio Technology Co., Ltd

Ever Supreme Bio Technology Co., Ltd

6712
Clasificación en acciones #13229
This enterprise is dedicated to the investigation, advancement, and creation of... This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
Precio por acción
$4.99
Capitalización bursátil
$508.03M
Cambio (1 día)
-2.48%
Cambio (1 año)
2.10%
País
TW
Comercio Ever Supreme Bio Technology Co., Ltd (6712)

Categoría

Healthcare
Ganancias de Ever Supreme Bio Technology Co., Ltd (6712)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Ever Supreme Bio Technology Co., Ltd, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Ever Supreme Bio Technology Co., Ltd desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH